State Street’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-177,447
| Closed | -$231K | – | 4287 |
|
|
2025
Q2 | $231K | Sell |
177,447
-316,343
| -64% | -$381K | ﹤0.01% | 3793 |
|
|
2025
Q1 | $686K | Buy |
493,790
+57,960
| +13% | +$127K | ﹤0.01% | 3517 |
|
|
2024
Q4 | $998K | Sell |
435,830
-17,466
| -4% | -$46.3K | ﹤0.01% | 3490 |
|
|
2024
Q3 | $1.23M | Buy |
453,296
+18,361
| +4% | +$44.8K | ﹤0.01% | 3447 |
|
|
2024
Q2 | $1.02M | Buy |
434,935
+6,608
| +2% | +$21.1K | ﹤0.01% | 3472 |
|
|
2024
Q1 | $2.01M | Buy |
428,327
+70,736
| +20% | +$367K | ﹤0.01% | 3278 |
|
|
2023
Q4 | $1.75M | Sell |
357,591
-432
| -0.1% | -$1.79K | ﹤0.01% | 3356 |
|
|
2023
Q3 | $1.66M | Buy |
358,023
+61,833
| +21% | +$355K | ﹤0.01% | 3400 |
|
|
2023
Q2 | $2.19M | Buy |
296,190
+22,981
| +8% | +$153K | ﹤0.01% | 3370 |
|
|
2023
Q1 | $2.23M | Buy |
273,209
+4,482
| +2% | +$46.8K | ﹤0.01% | 3299 |
|
|
2022
Q4 | $2.57M | Buy |
268,727
+35,606
| +15% | +$438K | ﹤0.01% | 3298 |
|
|
2022
Q3 | $2.74M | Buy |
233,121
+32,185
| +16% | +$424K | ﹤0.01% | 3318 |
|
|
2022
Q2 | $2.58M | Buy |
200,936
+18,645
| +10% | +$193K | ﹤0.01% | 3392 |
|
|
2022
Q1 | $2M | Buy |
182,291
+27,194
| +18% | +$315K | ﹤0.01% | 3562 |
|
|
2021
Q4 | $2.38M | Buy |
155,097
+48,118
| +45% | +$630K | ﹤0.01% | 3587 |
|
|
2021
Q3 | $1.49M | Buy |
106,979
+25,199
| +31% | +$421K | ﹤0.01% | 3693 |
|
|
2021
Q2 | $1.58M | Buy |
+81,780
| New | +$1.69M | ﹤0.01% | 3582 |
|
State Street's AKYA Position: Q3 2025 in Review
State Street sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 177,447 shares — an estimated $231K sold.
State Street first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $2.74M in Q3 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- State Street reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- State Street sold 177,447 Akoya BioSciences shares in Q3 2025, an estimated $231K.
- State Street first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- State Street's Akoya BioSciences position peaked at $2.74M in Q3 2022.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.